«This treatment has now been studied in our centre using the most sensitive measure of lung structure — a radiologic measurement of lung density — allowing us to detect changes far earlier than can be seen with standard breathing tests,» said Dr. Kenneth Chapman, Director of the Asthma and Airways Centre at Toronto Western Hospital and the Canadian research lead for the multicentre trial. (sciencedaily.com)
BSI member Dr Stephen Jolles, who led the study, says, «This study is the first time that the imaging technique, FDG PET - CT, has been used to assess the combined lung structure and metabolic activity in a patient with GLILD before and after treatment. (immunology.org)
«Augmentation therapy not only preserves lung structure, but likely adds years of life,» said Dr. Chapman. (sciencedaily.com)